P953: Establishment and Internal Validation of a Clinical Risk Score to Predict the Efficacy of Adalimumab in Crohn@E@s DiseaseECCO'24Year: 2024
Authors: Wang, F.(1);Liang, J.(2)*;
(1)State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases- Xijing Hospital of Digestive Diseases- Fourth Military Medical University, Digestive Disease, Xi@E@an, China;(2)Xijing hospital, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases- Xijing Hospital of Digestive Diseases- Fourth Military Medical University, Xi’an, China;
DOP01: The effect of vedolizumab on CD8 T cell repertoire homogeneity and blood-gut trafficking in patients with inflammatory bowel diseaseECCO’23 CopenhagenYear: 2023
Authors: Williams, K.(1);Shows, D.(2);Kongala, R.(2);Clarke, A.(3);Lord, J.(2)*;
(1)University of Colorado, Medicine, Denver, United States;(2)Benaroya Research Institute, Translational Research, Seattle, United States;(3)Seattle Genetics, Early Stage Ind to Medicine Research, Seattle, United States;
DOP02: Single cell RNA sequencing of Ulcerative Colitis and Crohn's Disease tissue samples informs the selection of Triggering Receptors Expressed on Myeloid Cells 1 (TREM1) as a target for the treatment of Inflammatory Bowel DiseasesECCO’23 CopenhagenYear: 2023
Authors: Grant, S.(1)*;Johnson, K.(1);Thomas, T.(2);Honig, G.(1);Bielecki, P.(1);Dendrou, C.(3);Guo, S.(1);Kulicke, R.(1);Li, P.(1);L'Italien, L.(1);Spies, N.(1);Stransky, N.(1);Uhlig, H.(4);Varma, M.(1);Travis, S.(5);Buckley, C.(2);Magram, J.(1);
(1)Celsius Therapeutics, Research and Development, Cambridge MA, United States;(2)Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom;(3)Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom;(4)Translational Gastroenterology Unit and Department of Pediatrics, University of Oxford, Oxford, United Kingdom;(5)Kennedy Institute and Translational Gastroenterology Unit, University of Oxford, Oxford, United Kingdom;
DOP03: Unfermented β-fructan fibres can induce gut inflammation and tumorigenesis in select Inflammatory Bowel Disease patients mediated by gut microbiotaECCO’23 CopenhagenYear: 2023
Authors: Voisin, A.(1);Mahmood, R.(2);Jeanson, T.L.(2);Bernstein, C.(2);Armstrong, H.(2)*;
(1)University of Manitoba, Medical Microbiology and Infectious Diseases, Winnipeg, Canada;(2)University of Manitoba, Internal Medicine, Winnipeg, Canada;IBD Clinical and Research Centre
DOP04: Single cell RNA sequencing reveals a potential role for IFNγ in priming circulating monocytes for intestinal inflammatory function in Crohn's Disease.ECCO’23 CopenhagenYear: 2023
Authors: Hornsby, E.(1)*;Gadhok, R.(1);Yadon, A.N.(2);Lindsay, J.O.(1);Stagg, A.J.(1);
(1)Queen Mary University of London, Blizard Institute, London, United Kingdom;(2)Gilead Sciences- Inc, 199 East Blaine Street, Seattle, United States;
DOP05: Single-cell RNAseq temporal analysis of ulcerative colitis patients undergoing tofacitinib treatment reveals a shift in myeloid cells towards pro-inflammatory phenotypes in refractory patientsECCO’23 CopenhagenYear: 2023
Authors: Melon, E.(1)*;Veny, M.(1);Corraliza, A.M.(1);Garrido-Trigo, A.(1);Esteller, M.(1);Rodrigo, M.(2);Verstockt, B.(3);Vermeire, S.(4);Masamunt, M.C.(1);Giner, Á.(1);Ordás, I.(1);Fernández-Clotet, A.(1);Ricart, E.(1);Panés, J.(1);Salas, A.(1);
(1)Institut d'Investigacions Biomèdiques August Pi i Sunyer IDIBAPS, Hospital Clinic of Barcelona - Inflammatory Bowel Disease Unit, Barcelona, Spain;(2)Institut d'Investigacions Biomèdiques August Pi i Sunyer IDIBAPS, Department of Pathology- Hospital Clínic, Barcelona, Spain;(3)KU Leuven, Department of Chronic Diseases- Metabolism and Ageing- Translational Research Center- Department of Gastroenterology and Hepatology- University Hospitals Leuven for Gastrointestinal Disorders TARGID, Leuven, Belgium;(4)KU Leuven, Department of Chronic Diseases- Metabolism and Ageing- Translational Research Center for Gastrointestinal Disorders TARGID- Department of Gastroenterology and Hepatology- University Hospitals Leuven, Leuven, Belgium;
DOP06: Deep characterization of IL-23 pathway in different gut segments and associated plasma biomarkers in inflammatory bowel diseaseECCO’23 CopenhagenYear: 2023
Authors: Cairns, J.(1)*;Monkley, S.(2);Tian, S.(3);Angermann, B.(2);Liu, Z.(4);Öberg, L.(5);Muthas, D.(2);Cabrera, C.(6);Rapsomaniki, E.(7);Fernández Llaneza, D.(7);Olsson, M.(8);Paraskos, J.(9);Ellison, G.(10);Khan, E.(11);Duncan, E.A.(12);Neisen, J.(13);Gehrmann, U.(5);Chamberlain, C.(3);
(1)AstraZeneca, Translational Science and Experimental Medicine- Research and Early Development- Respiratory and Immunology R&I- BioPharmaceuticals R&D, Mölndal, Sweden;(2)AstraZeneca, Translational Science & Experimental Medicine- Research and Early Development- Respiratory and Immunology R&I- BioPharmaceuticals R&D, Mölndal, Sweden;(3)AstraZeneca, Translational Science & Experimental Medicine- Research and Early Development- Respiratory and Immunology R&I- BioPharmaceuticals R&D, Granta Park, United Kingdom;(4)AstraZeneca, Translational Science & Experimental Medicine- Research and Early Development- Respiratory and Immunology R&I- BioPharmaceuticals R&D, Gaithersburg, United States;(5)AstraZeneca, Translational Science & Experimental Medicine- Research and Early Development- Respiratory and Immunology R&I- BioPharmaceuticals R&D-, Mölndal, Sweden;(6)AstraZeneca, Evidence- Real World Science & Analytics, Mölndal, Sweden;(7)AstraZeneca, Evidence- Real World Science & Analytics, Cambridge, United Kingdom;(8)AstraZeneca, BioPharma Early Biometrics and Statistical Innovation, Mölndal, Sweden;(9)AstraZeneca, Precision Medicine & Biosamples- Oncology R&D, Cambridge, United Kingdom;(10)AstraZeneca, Precision Medicine & Biosamples- Oncology R&D, Macclesfield, United Kingdom;(11)AstraZeneca, Clinical Development- Research and Late Development- Respiratory and Immunology R&I- BioPharmaceuticals R&D, Cambridge, United Kingdom;(12)AstraZeneca, Clinical Development- Research and Late Development- Respiratory and Immunology R&I- BioPharmaceuticals R&D, Durham, United States;(13)AstraZeneca, Translational Science & Experimental Medicine- Research and Early Development- Respiratory and Immunology R&I- BioPharmaceuticals R&D-, Granta Park, United Kingdom;
DOP07: Targeting the canonical WNT signalling pathway as a potential novel therapy in Crohn´s associated fibrosisECCO’23 CopenhagenYear: 2023
Authors: Buck, A.(1)*;Weber, M.C.(1);Friess, H.(1);Neumann, P.A.(1);
(1)Klinikum rechts der Isar- Technische Universität München, Klinik für Chirurgie, München, Germany;
DOP08: Cellular and molecular interaction of MAIT in mucosal tissue and their role in inflammatory bowel diseaseECCO’23 CopenhagenYear: 2023
Authors: Bosáková, V.(1,2)*;Frič, J.(1,3);
(1)St. Anne's University Hospital Brno, International Clinical Research Center, Brno, Czech Republic;(2)Masaryk University- Faculty of Medicine, Department of Biology, Brno, Czech Republic;(3)Institute of Hematology and Blood Transfusion, Department of Modern Immunotherapy, Prague, Czech Republic;
DOP09: Eosinophils exert a pro-inflammatory role in a chronic DSS colitis model without an impact on fibrosisECCO’23 CopenhagenYear: 2023
Authors: Jacobs, I.(1)*;Deleu, S.(2);Cremer, J.(1,2);De Hertogh, G.(3);Vermeire, S.(2,4);Breynaert, C.(1,5);Vanuytsel, T.(2,4);Verstockt, B.(2,4);
(1)KU Leuven, Department of Microbiology- Immunology and Transplantation, Leuven, Belgium;(2)KU Leuven, Department of Chronic Diseases and Metabolism, Leuven, Belgium;(3)KU Leuven, Department of Imaging and Pathology, Leuven, Belgium;(4)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(5)University Hospitals Leuven, Department of General Internal Medicine, Leuven, Belgium;
DOP10: Early intestinal resection in Crohn's Disease is not associated with severe long-term disease courseECCO’23 CopenhagenYear: 2023
Authors: Grellier, N.(1,2)*;Kirchgesner, J.(1);Uzzan, M.(3,4);Mclellan, P.(1);Stefanescu, C.(3,5);Lefèvre, J.H.(6);Panis, Y.(5,7);Sokol, H.(1);Beaugerie, L.(1);Treton, X.(3,5);Seksik, P.(1);
(1)Saint-Antoine Hospital - Assistance Publique Hôpitaux de Paris, Department of Gastroenterology, Paris, France;(2)Centre Hospitalier Universitaire de Poitiers, Department of Hepato-gastroenterology, Poitiers, France;(3)Beaujon Hospital - Assistance Publique Hôpitaux de Paris, Department of Gastroenterology - IBD unit, Clichy, France;(4)Henri Mondor Hospital - Assistance Publique Hôpitaux de Paris, Department of Gastroenterology, Créteil, France;(5)CMC Ambroise Pare - Hartmann, Paris IBD Center, Neuilly, France;(6)Saint-Antoine Hospital - Assistance Publique Hôpitaux de Paris, Department of Digestive Surgery, Paris, France;(7)Beaujon Hospital - Assistance Publique Hôpitaux de Paris, Department of Colorectal Surgery, Clichy, France;ERIC
DOP11: A novel diagnostic serum protein signature for paediatric Inflammatory Bowel Disease: A discovery and validation study in two independent inception cohortsECCO’23 CopenhagenYear: 2023
Authors: Bache-Wiig Mathisen, C.(1,2)*;Nyström, N.(3);Bazov, I.(4);Andersen, S.(5);Olbjørn, C.(6);Perminow, G.(7);Kristensen, V.A.(1,8);Opheim, R.(1,9);Ricanek, P.(10,11);D`Amato, M.(12,13,14);Carlson, M.(15);Hedin, C.R.(16,17);Keita, Å.V.(18);Kruse, R.(19);Lindqvist, C.M.(20);Magnusson, M.K.(21);Salihovic, S.(22,23);Söderholm, J.D.(18);Öhman, L.(21);Repsilber, D.(4);Høivik, M.L.(1,2);Halfvarson, J.(24);
(1)Oslo University Hospital, Department of Gastroenterology, Oslo, Norway;(2)University of Oslo, Institute of Clinical Medicine, Oslo, Norway;(3)Uppsala Univeristy Hospital, Department of Women's and Children's health, Uppsala, Sweden;(4)Örebro University, School of Medical Sciences, Örebro, Sweden;(5)Vestfold Hospital trust, Department of Pediatrics, Tønsberg, Norway;(6)Akershus University Hospital, Department of Pediatric and Adolescent Medicine, Lørenskog, Norway;(7)Oslo University Hospital, Department of Pediatric Medicine, Oslo, Norway;(8)Lovisenberg Diaconal Hospital, Unger-Vetlesen Institute, Oslo, Norway;(9)University of Oslo, Faculty of Medicine, Oslo, Norway;(10)Lovisenberg Diaconal Hospital, Department of Gastroenterology, Oslo, Norway;(11)Akershus University Hospital, Department of Gastroenterology, Lørenskog, Norway;(12)Karolinska Institutet, Clinical Epidemiology Division- Department of Medicine Solna, Stockholm, Sweden;(13)IKERBASQUE, Basque Foundation for Science, Bilbao, Spain;(14)CIC bioGUNE - BRTA, Gastrointestinal Genetics Lab, Derio, Spain;(15)Uppsala University, Department of Medical Sciences, Uppsala, Sweden;(16)Karolinska Institute, Department of Medicine Solna, Stockholm, Sweden;(17)Karolinska University Hospital, Gastroenterology unit- Department of Gastroenterology- Dermatovenereology and Rheumatology, Oslo, Sweden;(18)Linköping University, Department of Biomedical and Clinical Sciences, Linköping, Sweden;(19)Örebro University, Department of Clinical Research Laboratory- Faculty of Medicine and Health, Örebro, Sweden;(20)Örebro University, School of Medical Sciences- Faculty of Medicine and Health, Örebro, Sweden;(21)University of Gothenburg, Department of Microbiology and Immunology- Institute of Biomedicine- Sahlgrenska Academy, Gothenburg, Sweden;(22)Örebro University, School of Medical Sciences - Inflammatory Response and Infection Susceptibility Centre, Örebro, Sweden;(23)Örebro University, School of Science and Technology- MTM Research Centre, Örebro, Sweden;(24)Örebro University, Department of Gastroenterology- Faculty of Medicine and Health, Örebro, Sweden;
DOP12: Validation of radiomics features on MR enterography characterizing inflammation and fibrosis in stricturing Crohn's diseaseECCO’23 CopenhagenYear: 2023
Authors: Sleiman, J.(1)*;Chirra, P.(2);Gandhi, N.(3);Gordon, I.O.(4);Viswanath, S.(2);Rieder, F.(5,6);
(1)University of Pittsburgh Medical Center, Department of Gastroenterology- Hepatology & Nutrition, Pittsburgh, United States;(2)Case Western Reserve University, Department of Biomedical Engineering, Cleveland, United States;(3)Cleveland Clinic Foundation, Imaging Institute, Cleveland, United States;(4)Cleveland Clinic Foundation, Department of Pathology- Robert J Tomsich Pathology and Laboratory Medicine Institute, Cleveland, United States;(5)Cleveland Clinic Foundation, Department of Gastroenterology- Hepatology & Nutrition- Digestive Diseases and Surgery Institute, Cleveland, United States;(6)Lerner Research Institute, Department of Inflammation and Immunity, Cleveland, United States;Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium
DOP13: Plasma metabolite fingerprint could discriminate inflammatory bowel disease patients from healthy subjectsECCO’23 CopenhagenYear: 2023
Authors: Farkas, K.(1)*;Endre, G.(2);Bacsur, P.(1);Resál, T.(1);Kocsmárszky-Koósz, V.(2);Tömösi, F.(2);Tóth, E.(2);Rutka, M.(1);Bálint, A.(1);Fábián, A.(1);Bor, R.(1);Szepes, Z.(1);Goretity, Á.(2);Thibodeau, I.(2);Molnár, T.(1);
(1)Szent-Györgyi Albert Medical School- University of Szeged, Department of Medicine, Szeged, Hungary;(2)MP Health Ltd., MP Health Ltd., Budapest, Hungary;
DOP14: Identification and validation of a lipidomic signature as a novel diagnostic biomarker of paediatric Inflammatory Bowel DiseaseECCO’23 CopenhagenYear: 2023
Authors: Salihovic, S.(1);Nyström, N.(2)*;Bache-Wiig Mathisen, C.(3);Andersen, S.(4);Olbjørn, C.(5);Perminow, G.(6);Opheim, R.(7);Detlie, T.E.(8);Huppertz-Hauss, G.(9);Bazov, I.(1);Kruse, R.(10);Lindqvist, C.M.(1);Hedin, C.R.H.(11);Carlson, M.(12);Öhman, L.(13);Magnusson, M.(13);Keita, Å.V.(14);Söderholm, J.D.(14);D'Amato, M.(15);Orešič, M.(1);Repsilber, D.(1);Hyötyläinen, T.(16);Hoivik, M.L.(3);Halfvarson, J.(17);
(1)School of Medical Sciences- Faculty of Medicine and Health, Örebro University, Örebro, Sweden;(2)Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden;(3)Department of Gastroenterology- Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway;(4)Department of Pediatrics, Vestfold Hospital trust, Tønsberg, Norway;(5)Department of Pediatrics and Adolescent Medicine, Akershus University Hospital, Lørenskog, Norway;(6)Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway;(7)Department of Gastroenterology- Oslo University Hospital and Faculty of Medicine, University of Oslo, Oslo, Norway;(8)Department of Gastroenterology- Akershus University Hospital and Institute of Clinical Medicine, University of Oslo, Lørenskog, Norway;(9)Department of Gastroenterology, Telemark Hospital Trust, Skien, Norway;(10)Department of Clinical Research Laboratory- Faculty of Medicine and Health, Örebro University, Örebro, Sweden;(11)Department of Medicine Solna and Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden;(12)Department of Medical Sciences, Uppsala University, Uppsala, Sweden;(13)Department of Microbiology and Immunology and Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;(14)Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden;(15)Clinical Epidemiology Division- Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden;(16)School of Science and Technology, Örebro University, Örebro, Sweden;(17)Department of Gastroenterology- Faculty of Medicine and Health, Örebro University, Örebro, Sweden;
DOP15: Intestinal ultrasound correlates with colonoscopy and biomarkers, and can be used in a tight monitoring approach to assess response to therapy in Crohn's disease: a multicentre prospective studyECCO’23 CopenhagenYear: 2023
Authors: Morão, B.(1)*;Revés, J.(1);Nascimento, C.(1);Frias Gomes, C.(1);Cúrdia Gonçalves, T.(2);Freitas, M.(2);Castro, F.(2);Moreira, M.J.(2);Cotter, J.(2);Pereira, F.(3);Caldeira, A.(3);Sousa, R.(3);Coelho, R.(4);Macedo, G.(4);Macedo, C.(5);Ferreira, M.(5);Glória, L.(1);Torres, J.(1);Palmela, C.(1);
(1)Hospital Beatriz Ângelo, Gastroenterology, Lisbon, Portugal;(2)Hospital da Senhora da Oliveira - Life and Health Sciences Research Institute - School of Medicine - University of Minho - Braga - ICVS/3B's - PT Government Associate Laboratory, Gastroenterology, Guimarães/Braga, Portugal;(3)Unidade Local de Saúde de Castelo Branco- EPE- Hospital Amato Lusitano, Gastroenterology, Castelo Branco, Portugal;(4)Centro Hospitalar de São João, Gastroenterology, Porto, Portugal;(5)Centro Hospitalar Universitário de Coimbra, Gastroenterology, Coimbra, Portugal;
DOP16: Anti-integrin ⍺vβ6 autoantibodies predate Ulcerative Colitis diagnosis by up to 10 years and are associated with adverse disease-related outcomesECCO’23 CopenhagenYear: 2023
Authors: Livanos, A.(1)*;Dunn, A.(2);Fischer, J.(2);Ungaro, R.C.(1);Turpin, W.(3);Lee, S.H.(3);Rui, S.(1);Del Valle, D.M.(2);Jougon, J.J.(4);Martinez-Delgado, G.(2);Riddle, M.S.(5);Murray, J.A.(6);Laird, R.M.(7);Torres, J.(8);Agrawal, M.(1);Magee, J.S.(9);Dervieux, T.(10);Gnjatic, S.(2);Sheppard, D.(11);Sands, B.E.(1);Porter, C.K.(7);Croitoru, K.(3);Petralia, F.(12);Colombel, J.F.(1);Mehandru, S.(1);
(1)Icahn School of Medicine at Mount Sinai, Henry D. Janowitz Division of Gastroenterology, New York, United States;(2)Icahn School of Medicine at Mount Sinai, Precision Immunology Institute, New York, United States;(3)Mount Sinai Hospital, Zane Cohen Centre for Digestive Diseases, Toronto- Ontario, Canada;(4)Claude Huriez Hospital- University of Lille, Hepato-Gastroenterology Department, Lille, France;(5)University of Nevada- Reno School of Medicine, Office of Medical Research, Reno, United States;(6)Mayo Clinic, Division of Gastroenterology and Hepatology, Rochester, United States;(7)Naval Medical Research Center, Enteric Diseases Department, Silver Spring, United States;(8)Hospital Beatriz Ângelo, Gastroenterology Division, Loures, Portugal;(9)Walter Reed National Military Medical Center, Gastroenterology, Bethesda, United States;(10)Prometheus Laboratories, Chief Scientific Officer, San Diego, United States;(11)University of California San Francisco, Division of Pulmonary- Critical Care- Allergy and Sleep- Department of Medicine, San Francisco, United States;(12)Icahn School of Medicine at Mount Sinai, Department of Genetics and Genomic Sciences, New York, United States;CCC-GEM Project Research Consortium and OSCCAR Consortium
DOP17: HIV infection is associated with a less aggressive phenotype of inflammatory bowel disease. A multicenter study based on the ENEIDA registry.ECCO’23 CopenhagenYear: 2023
Authors: Calafat Sard, M.(1,2)*;Súria, C.(3);Mesonero, F.(4);de Francisco, R.(5);Yagüe Caballero, C.(6);de la Peña, L.(7);Hernández-Camba, A.(8);Marcè, A.(9);Gallego, B.(10);Martín-Vicente, N.(11);Rivero, M.(12); Iborra, M.(13);Guerra, I.(14); Carrillo-Palau, M.(15);Madero, L.(16);Burgueño, B.(17); Montfort, D.(18);Torres, G.(19);Teller, M.(20);Ferrer Rosique, J.Á.(21);Vega Villaamil, P.(22);Roig, C.(23);Ponferrada, Á.(24); Betoré Glaría, E.(25);Zabana, Y.(2,26); P. Gisbert, J.(2,27);Alcaide, N.(28);Camps, B.(29);Legido, J.(30);González Vivo, M.(31);Bosca-Watts, M.M.(32);Pérez-Martínez, I.(5);Casas Deza, D.(6,33);Guardiola, J.(7);Arranz Hernández, L.(8); Navarro, M.(34);Gomollon, F.(2,10);Cañete, F.(1,2); Mañosa, M.(1,2);Domènech, E.(1,2);
(1)Hospital Universitari Germans Trias i Pujol, Gastroenterology department, Badalona, Spain;(2)CIBERehd, Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas, Madrid, Spain;(3)Hospital Clínic Universitari de València- Universitat de València, Gastroenterology Department, Valencia, Spain;(4)Hospital Universitario Ramón y Cajal, Gastroenterology Department, Madrid, Spain;(5)Hospital Universitario Central de Asturias- Instituto de Investigación Sanitaria del Principado de Asturias ISPA, Gastroenterology Department, Oviedo, Spain;(6)Hospital Universitario Miguel Servet, Gastroenterology Department, Zaragoza, Spain;(7)Hospital Universitari de Bellvitge, Gastroenterology Department, L'hospitalet de Llobregat, Spain;(8)Hospital Universitario Nuestra Señora de Candelaria, Gastroenterology Department, Santa Cruz de Tenerife, Spain;(9)Hospital de Sant Joan Despí Moisès Broggi, Gastroenterology Department, Sant Joan Despí, Spain;(10)Hospital Clínico Universitario «Lozano Blesa»- Instituto de Investigación Sanitaria- IIS Aragón, Gastroenterology Department, Zaragoza, Spain;(11)Hospital Universitario de Galdakao, Gastroenterology Department, Galdakao, Spain;(12)Hospital Universitario Marqués de Valdecilla- Instituto de Investigación Marqués de Valdecilla IDIVAL, Gastroenterology Department, Santander, Spain;(13)Hospital Universitari i Politècnic la Fe de València, Gastroenterology Department, Valencia, Spain;(14)Hospital Universitario de Fuenlabrada e IdiPAZ, Gastroenterology Department, Fuenlabrada, Spain;(15)Hospital Universitario de Canarias, Gastroenterology Department, La Laguna, Spain;(16)Hospital General Universitario Dr Balmis de Alicante. ISABIAL, Gastroenterology Department, Alicante, Spain;(17)Hospital Rio Hortega, Gastroenterology Department, Valladolid, Spain;(18)Consorci Sanitari de Terrassa, Gastroenterology Department, Terrassa, Spain;(19)Hospital Universitari Arnau de Vilanova de Lleida, Gastroenterology Department, Lleida, Spain;(20)Althaia- Xarxa Assistencial Universitària de Manresa, Gastroenterology Department, Manresa, Spain;(21)Hospital Universitario Fundación Alcorcón, Gastroenterology Department, Alcorcón, Spain;(22)Complexo Hospitalario Universitario de Ourense, Gastroenterology Department, Ourense, Spain;(23)Hospital Universitari de la Santa Creu i Sant Pau, Gastroenterology Department, Barcelona, Spain;(24)Hospital Universitario Infanta Leonor, Gastroenterology Department, Madrid, Spain;(25)Hospital Universitario San Jorge, Gastroenterology Department, Huesca, Spain;(26)Hospital Universitari Mútua de Terrassa, Gastroenterology Department, Terrassa, Spain;(27)Hospital Universitario de la Princesa- IIS-Princesa- UAM- Madrid, Gastroenterology Department, Madrid, Spain;(28)Hospital Clínico de Valladolid, Gastroenterology Department, Valladolid, Spain;(29)Hospital de Granollers, Gastroenterology Department, Granollers, Spain;(30)Complejo Asistencial de Segovia, Gastroenterology Department, Segovia, Spain;(31)Hospital Parc de Salut Mar, Gastroenterology Department, Barcelona, Spain;(32)Hospital Clínic Universitari de València- Universitat de València, Gastroenterology Department, València, Spain;(33)Instituto de Investigación Sanitaria de Aragón IISA., Gastroenterology, Zaragoza, Spain;(34)Hospitalde Sant Joan Despí Moisès Broggi, Gastroenterology Department, Sant Joan Despí, Spain;on behalf of GETECCU.
DOP18: Brain structural correlates of fatigue in active and quiescent Crohn's DiseaseECCO’23 CopenhagenYear: 2023
Authors: Thomann, A.(1)*;Schmitgen, M.(2);Szabo, K.(3);Ebert, M.(4);Reindl, W.(4);Wolf, C.(5);
(1)University Medical Center Mannheim- Medical Faculty Mannheim- Heidelberg University- Mannheim- Germany, Department of Medicine II, Mannheim, Germany;(2)Heidelberg University Hospital, Dept. of General Psychiatry, Heidelberg, Germany;(3)University Medical Centre Mannheim- Heidelberg University, Dept. of Neurology, Mannheim, Germany;(4)University Medical Centre Mannheim- Heidelberg University, Dept. of Medicine II, Mannheim, Germany;(5)Heidelberg University Hospital, Department of General Psychiatry, Heidelberg, Germany;
DOP19: Incidence and initial disease presentation of inflammatory bowel diseases in Denmark: findings from a Copenhagen IBD Inception Cohort Study (IBD Prognosis Study)ECCO’23 CopenhagenYear: 2023
Authors: Attauabi, M.(1,2)*;Madsen, G.R.(2,3);Wewer, A.V.(2,4);Bendtsen, F.(2,3);Jakobsen, C.(2,4);Dorn-Rasmussen, M.(2,4);Malham, M.(2,4);Theede, K.(2,3);Bjerrum, J.T.(1);Boysen, T.(2,3);Seidelin, J.B.(1);Burisch, J.(2,3);
(1)Copenhagen University Hospital - Herlev and Gentofte, Department of Gastroenterology and Hepatology, Herlev, Denmark;(2)Hvidovre Hospital, Copenhagen Center for Inflammatory Bowel Disease in Children- Adolescents- and Adults, Hvidovre, Denmark;(3)Copenhagen University Hospital - Amager and Hvidovre, Gastrounit- Medical Section, Hvidovre, Denmark;(4)Copenhagen University Hospital - Amager and Hvidovre, Department of Pediatrics and Adolescent Medicine, Hvidovre, Denmark;